Crossmark

A Low Grade Nasopharyngeal sarcoma With FUS::NACC1 Fusion and Immunohistochemical Evidence of Epithelial Differentiation: Expanding the Clinicopathologic Spectrum of an Emerging Entity

Crossref DOI link: https://doi.org/10.1007/s12105-022-01488-9

Published Online: 2022-09-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rooper, Lisa M. https://orcid.org/0000-0001-5636-9753
Gagan, Jeffrey

Bishop, Justin A.
Funding

Funding for this research was provided by:

The Jane B. and Edwin P. Jenevein M.D Endowment for Pathology at UT Southwestern Medical Center (NA)
License Information

Text and Data Mining valid from 2022-09-28

Version of Record valid from 2022-09-28
More Information

Article History

Received: 27 June 2022

Revised: 9 August 2022

Accepted: 11 August 2022

First Online: 28 September 2022

Declarations and Compliance with Ethical Standards

:

: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

: All procedures performed in this retrospective data analysis involving human participants were in accordance with the ethical standards of the institutional review board (Johns Hopkins Medicine IRB 00176183 and UT Southwestern IRB 112017-073).

: The IRB-approved study did not require informed consent.

Document is current

Any future updates will be listed below